封面
市场调查报告书
商品编码
1629894

全球机械呼吸器市场 - 2025-2033

Global Mechanical Ventilator Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年,全球机械呼吸器市场规模达30.3亿美元,预计2033年将达到46.3亿美元,2025-2033年预测期间复合年增长率为4.2%。

机械呼吸器是生命维持设备,可帮助或取代无法自主呼吸的患者的自主呼吸。它们将受控气流输送到肺部,确保适当的氧合和二氧化碳去除。它们用于 ICU、手术室和急诊等重症监护环境,可治疗因 ARDS、COPD 或创伤等疾病引起的呼吸衰竭。它们有侵入式和非侵入式两种型号,提供先进的功能,可根据患者的个人需求量身定制通气设置,从而改善结果并减少併发症。

市场动态:

驱动程式和限制

呼吸器技术的进步

全球机械呼吸器市场由技术进步推动,包括便携式和轻型设计、整合监控系统、无线连接和人工智慧演算法。这些功能可实现个人化的通气策略并改善患者的治疗效果。非侵入性通气系统减少了侵入性手术的需要,提高了患者的舒适度并降低了风险。这些技术改进不仅扩展了机械呼吸器的组件,还满足了不同患者群体对高效、用户友好且适应性强的呼吸护理解决方案不断增长的需求。

例如,2024 年 2 月,Getinge 在印度推出了 Servo-c 机械呼吸机,旨在满足儿科和成人患者的多样化呼吸需求。该呼吸器提供肺部保护性治疗工具,是印度各地医院向提供先进且负担得起的先进医疗保健解决方案迈出的重要一步。随着医疗保健成本不断上升,人们越来越注重投资安全、高品质和永续的解决方案。 Getinge 的 Servo-c 借鉴了 50 多年的 Servo 性能,旨在简化呼吸支援并以合理的价格提供最先进的设备。

呼吸器成本高

全球机械呼吸器市场因成本高而面临挑战,特别是在中低收入国家。具有整合监测系统和人工智慧等先进功能的先进呼吸机价格较便宜,限制了小型医院和家庭护理机构的采用。维护、消耗品和操作员培训费用也增加了财务负担。这些因素阻碍了广泛采用,特别是在医疗预算有限的地区,影响了市场的成长潜力。

例如,高敏锐度呼吸器是医院重症监护室最受欢迎的呼吸器类型。这些呼吸器具有基于涡轮的供气和比例电磁气体输送系统 (PSOL),用于治疗患有严重呼吸道疾病或感染的患者。它们的价格在 20,000 美元到 55,000 美元之间,通常用于家庭护理和便携式呼吸机。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 呼吸器技术的进步
    • 限制
      • 呼吸器成本高
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章:依产品类型

  • 重症监护呼吸机
    • 容量控制呼吸机
    • 压力控制呼吸机
    • 组合模式呼吸机
  • 便携式/运输呼吸机
  • 新生儿呼吸机

第 7 章:按组件

  • 呼吸器
  • 呼吸器配件

第 8 章:依通气模式分类

  • 侵入性通气
  • 非侵入性通气

第 9 章:最终用户

  • 医院
  • 门诊手术中心
  • 家庭护理设置
  • 紧急情况和交通设置
  • 长期照护中心

第 10 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章:公司简介

  • Medtronic Plc
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Philips Healthcare
  • Hamilton Medical AG
  • GE Healthcare
  • Dragerwerk AG & Co. KGaA
  • Vyaire Medical, Inc.
  • Smith's Medical
  • ResMed Inc.
  • Fisher & Paykel Healthcare Corporation Limited
  • Allied Healthcare Products, Inc.

第 13 章:附录

简介目录
Product Code: MD880

The global Mechanical Ventilator market reached US$ 3.03 billion in 2023 and is expected to reach US$ 4.63 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025-2033.

Mechanical ventilators are life-support devices that assist or replace spontaneous breathing in patients who cannot breathe on their own. They deliver controlled airflow into the lungs, ensuring proper oxygenation and carbon dioxide removal. Used in critical care settings like ICUs, operating rooms, and emergency departments, they manage respiratory failure caused by conditions like ARDS, COPD, or trauma. Available in invasive and non-invasive models, they offer advanced features to tailor ventilation settings to individual patient needs, improving outcomes and reducing complications.

Market Dynamics: Drivers & Restraints

Advancements in Ventilator Technology

The global mechanical ventilator market is driven by technological advancements, including portable and lightweight designs, integrated monitoring systems, wireless connectivity, and artificial intelligence algorithms. These features enable personalized ventilation strategies and improved patient outcomes. Non-invasive ventilation systems reduce the need for invasive procedures, enhancing patient comfort and reducing risks. These technological improvements not only expand the Components of mechanical ventilators but also meet the growing demand for efficient, user-friendly, and adaptable respiratory care solutions across diverse patient populations.

For instance, in February 2024, Getinge has launched its Servo-c mechanical ventilator in India, designed to address the diverse respiratory needs of pediatric and adult patients. The ventilator offers lung-protective therapeutic tools and is a significant step towards making advanced healthcare solutions accessible and affordable for hospitals across India. With rising healthcare costs, there is an increased focus on investing in safe, high-quality, and sustainable solutions. Getinge's Servo-c, drawing from over 50 years of Servo performance, aims to simplify respiratory support and provide access to state-of-the-art equipment at a reasonable price.

High Cost of Ventilators

The global mechanical ventilator market faces challenges due to high costs, particularly in low- and middle-income countries. Advanced ventilators with advanced features like integrated monitoring systems and artificial intelligence are less affordable, limiting adoption in smaller hospitals and homecare settings. Maintenance, consumables, and operator training expenses also add to the financial burden. These factors hinder widespread adoption, especially in regions with limited healthcare budgets, affecting the market's growth potential.

For instance, High-acuity ventilators are the most sought-after type of ventilator for intensive care units in hospitals. These ventilators, which have a turbine-based air supply and proportional solenoid gas delivery system (PSOL), are used to treat patients with severe respiratory illnesses or infections. They can cost between $20,000 and $55,000 and are commonly used in home care and portable ventilators.

Segment Analysis

The global mechanical ventilator market is segmented based on product type, component, mode of ventilation, end user and region.

Product Type:

Critical Care Ventilators segment is expected to dominate the Mechanical Ventilator market share

The critical care ventilators segment holds a major portion of the mechanical ventilator market share and is expected to continue to hold a significant portion of the mechanical ventilator market share during the forecast period.

Critical care ventilators are essential in managing severe respiratory conditions in intensive care units (ICUs). They provide precise and reliable support for patients with ARDS, COPD, and other critical conditions. Their customizable ventilation modes, real-time monitoring, and integration with hospital systems make them a preferred choice for healthcare professionals. The rising prevalence of life-threatening respiratory disorders and the increasing number of ICU admissions have fueled demand for critical care ventilators, making them a cornerstone of the mechanical ventilator market.

For instance, in July 2024, Air Liquide Medical Systems has introduced the Monnal TEO, a French ventilator designed for intensive care and critical care services. The ventilator, manufactured in France, was developed in collaboration with the Angers University Hospital's intensive care unit, aiming to improve ventilatory care for patients with acute respiratory failure. The company continues to be a pioneer in mechanical ventilation.

End User:

Hospitals segment is the fastest-growing segment in Mechanical Ventilator market share

The hospitals segment is the fastest-growing segment in the mechanical ventilator market share and is expected to hold the market share over the forecast period.

Hospitals are the primary users of mechanical ventilators, as they require advanced respiratory care solutions for critically ill patients. The increasing prevalence of respiratory diseases, ICU admissions, and surgeries requiring post-operative ventilation support have boosted the adoption of ventilators in hospitals. Investments in healthcare infrastructure and government initiatives to equip hospitals with advanced medical devices are driving market growth. Hospitals' reliance on ventilators for emergency and long-term care solidifies their central role in shaping the mechanical ventilator market landscape.

For instance, according to Society of Critical Care Medicine Over 5 million patients are admitted to U.S. ICUs annually for monitoring, support, stabilization, management, and comfort. Although diverse, all ICU patients require frequent assessments, clinical expertise, and technological support. They require more clinical expertise than non-ICU patients, requiring a greater focus on comfort and care.

Geographical Analysis

North America is expected to hold a significant position in the Mechanical Ventilator market share

North America holds a substantial position in the mechanical ventilator market and is expected to hold most of the market share due to its advanced healthcare infrastructure, high prevalence of respiratory diseases, FDA clearance and significant healthcare expenditures. The US is particularly significant due to the increasing demand for ventilators due to chronic respiratory conditions like COPD, asthma, and sleep apnea. The aging population and a strong healthcare system contribute to the demand for advanced respiratory care solutions.

For instance, in November 2024, CorVent Medical has received FDA 510(k) clearance for its RESPOND ventilator, a cost-effective, smart ventilation system designed to provide quality care for healthcare systems, providers, and patients. The ventilator is a lightweight, easy-to-use system that combines traditional mechanical ventilation with durable components, eliminating the need for service and maintenance contracts. It comes with a 5-year Limited Warranty, making the total cost of ownership the purchase price. The RESPOND ventilator uses non-proprietary circuits and accessories for long-term affordability.

Moreover, in October 2024, Nihon Kohden America, a global medical technology leader, has introduced the NKV-440 Ventilator System, previously available through OrangeMed, to a wider range of healthcare providers.

Furthermore, government initiatives, such as substantial funding for hospitals and strategic stockpiling of medical equipment, further support the market's growth. North American hospitals invest heavily in ventilator technologies, including high-end critical care ventilators with customizable settings, real-time monitoring, and artificial intelligence-driven decision support.

Europe is growing at the fastest pace in the Mechanical Ventilator market

Europe holds the fastest pace in the mechanical ventilator market and is expected to hold most of the market share due to the aging population, increasing respiratory disorders, and advancements in medical technologies. The region's elderly population, particularly those with chronic respiratory diseases like COPD, pneumonia, and asthma, has a high demand for ventilators in both hospitals and homecare settings. The COVID-19 pandemic accelerated this demand, leading to rapid advancements in ventilator production and government policies to increase availability. Countries like Italy, Germany, and the UK expanded their healthcare budgets to ensure hospitals were well-equipped to handle respiratory crises.

For instance, in November 2024, The British Thoracic Society (BTS) has released its Model of Care for Complex Home Mechanical Ventilation (HMV), aiming to establish standards of care and provide guidance on infrastructure and resourcing for ventilatory failure patients in the UK. HMV is used to support patients with respiratory, neuromuscular, and chest wall disorders, and is beneficial for conditions like Chronic Obstructive Pulmonary Disease, Obesity-Related Respiratory Failure, Motor Neurone Disease, and Duchenne Muscular Dystrophy.

Competitive Landscape

The major global players in the mechanical ventilator market include Medtronic plc, Philips Healthcare, Hamilton Medical AG, GE Healthcare, Dragerwerk AG & Co. KGaA, Vyaire Medical, Inc., Smiths Medical, ResMed Inc, Fisher & Paykel Healthcare Corporation Limited, Allied Healthcare Products, Inc and among others.

Key Developments

  • In September 2024, Inspira Technologies, a medical technology company, has secured an additional U.S. patent for the VORTX orbiting blood oxygenation delivery system, a core technology of the INSPIRA ART device. This brings the total number of claims deemed novel related to the INSPIRA ART device to 32.
  • In October 2024, Nihon Kohden America has expanded the availability of its NKV-440 Ventilator System to a wider range of healthcare providers, enhancing respiratory support and helping overcome challenges like staff shortages and budget limitations.

Emerging Players

The emerging players in the mechanical ventilator market include AgVa Healthcare, Fritz Stephan GmbH, Dima Italia and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global mechanical ventilator market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Component
  • 3.3. Snippet by Mode of Ventilation
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advancements in Ventilator Technology
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Ventilators
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Critical Care Ventilators*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Volume-Controlled Ventilators
    • 6.2.4. Pressure-Controlled Ventilators
    • 6.2.5. Combined Mode Ventilators
  • 6.3. Portable/Transport Ventilators
  • 6.4. Neonatal Ventilators

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Ventilator Machines*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ventilator Accessories

8. By Mode of Ventilation

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 8.1.2. Market Attractiveness Index, By Mode of Ventilation
  • 8.2. Invasive Ventilation*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Non-Invasive Ventilation

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgery Centers
  • 9.4. Home Care Settings
  • 9.5. Emergency and Transport Settings
  • 9.6. Long-Term Care Centers

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic Plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Philips Healthcare
  • 12.3. Hamilton Medical AG
  • 12.4. GE Healthcare
  • 12.5. Dragerwerk AG & Co. KGaA
  • 12.6. Vyaire Medical, Inc.
  • 12.7. Smith's Medical
  • 12.8. ResMed Inc.
  • 12.9. Fisher & Paykel Healthcare Corporation Limited
  • 12.10. Allied Healthcare Products, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us